A detailed history of Invesco Ltd. transactions in Veru Inc. stock. As of the latest transaction made, Invesco Ltd. holds 62,607 shares of VERU stock, worth $44,450. This represents 0.0% of its overall portfolio holdings.

Number of Shares
62,607
Previous 62,720 0.18%
Holding current value
$44,450
Previous $52,000 7.69%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$0.77 - $1.04 $87 - $117
-113 Reduced 0.18%
62,607 $48,000
Q2 2024

Aug 13, 2024

BUY
$0.76 - $1.79 $47,667 - $112,268
62,720 New
62,720 $52,000
Q1 2023

May 12, 2023

BUY
$1.16 - $6.41 $1,035 - $5,724
893 Added 3.25%
28,360 $32,000
Q4 2022

Feb 13, 2023

SELL
$4.78 - $15.01 $12,882 - $40,451
-2,695 Reduced 8.94%
27,467 $145,000
Q3 2022

Nov 14, 2022

SELL
$10.22 - $23.7 $6.75 Million - $15.7 Million
-660,658 Reduced 95.63%
30,162 $348,000
Q2 2022

Aug 15, 2022

BUY
$4.35 - $15.85 $2.89 Million - $10.5 Million
664,713 Added 2546.11%
690,820 $7.81 Million
Q1 2022

May 16, 2022

SELL
$4.55 - $6.41 $2,830 - $3,987
-622 Reduced 2.33%
26,107 $127,000
Q4 2021

Feb 14, 2022

SELL
$5.89 - $9.73 $65,891 - $108,849
-11,187 Reduced 29.5%
26,729 $158,000
Q3 2021

Nov 15, 2021

BUY
$6.78 - $9.89 $51,399 - $74,976
7,581 Added 24.99%
37,916 $323,000
Q2 2021

Aug 17, 2021

SELL
$7.24 - $11.2 $6.78 Million - $10.5 Million
-936,781 Reduced 96.86%
30,335 $245,000
Q1 2021

May 17, 2021

SELL
$8.05 - $20.78 $774,450 - $2 Million
-96,205 Reduced 9.05%
967,116 $10.4 Million
Q4 2020

Feb 16, 2021

BUY
$2.36 - $9.99 $2.51 Million - $10.6 Million
1,063,321 New
1,063,321 $9.2 Million
Q1 2019

May 15, 2019

SELL
$1.2 - $1.59 $13,435 - $17,801
-11,196 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$1.21 - $1.54 $13,547 - $17,241
11,196 New
11,196 $16,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $56.9M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.